Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
2025 Q2 -tulosraportti
212 päivää sitten

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1 200--
1 400--
1 500--
651--
7 445--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
15.4.
Menneet tapahtumat
2025 Q2 -tulosraportti
28.8.2025
2024 Q4 -tulosraportti
10.4.2025
2024 Q2 -tulosraportti
29.8.2024
2023 Q4 -tulosraportti
25.4.2024
2023 Q3 -tulosraportti
9.11.2023

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 t sitten
    ·
    1 t sitten
    ·
    I'm very new to the game, but I've read up as much as I can on the stock. Nevertheless, I'm struggling to figure out what to do when it comes to when I should sell - yes, I can afford to lose the money, but it's still annoying. Does anyone have an opinion on what might happen this week, before Easter fully kicks off? I'm very keen to hold onto the stock as long as there is positive news
    16 min sitten
    ·
    16 min sitten
    ·
    If it were that simple to tell you what's going to happen next, there would be many stock market millionaires in the world.
  • 2 t sitten
    2 t sitten
    2 t sitten
    ·
    2 t sitten
    ·
    Strong 👍
  • 4 t sitten · Muokattu
    ·
    4 t sitten · Muokattu
    ·
    What do people think about CRNA now before Easter? I personally have rock-solid faith in CRNA, both in the short and long term. But do you think we'll see more buying pressure ig FOMO leading up to the Easter market close, or that people will secure profits and call it a day?
    2 t sitten
    ·
    2 t sitten
    ·
    I am also ready to buy more myself if it goes down.
    7 min sitten
    ·
    7 min sitten
    ·
    Yes
  • 6 t sitten
    ·
    6 t sitten
    ·
    I see that Collao finds it exciting to follow Circio at ASGCT's annual conference in Boston. Perhaps not everyone fully understands why. ASGCT profiling practically means that a company gains visibility and professional legitimacy at ASGCT, which is the largest and most central conference in gene and cell therapy. ASGCT describes the annual meeting as the largest and most comprehensive event in the field, with 7,000+ participants, 320+ exhibitors, and an audience that includes researchers, industry leaders, regulators, and clinicians. For Circio, it more specifically means three things: 1. Professional validation If an abstract is accepted, and especially if it is chosen for oral presentation, it is a mark of quality. Circio announced on March 18, 2026, that they had submitted two abstracts to ASGCT 2026, where one was chosen for oral presentation and one for a poster. The abstracts were to be published on April 13, 2026. 2. Increased visibility towards partners and investors ASGCT is not just an academic conference. It also gathers potential partners, BD people, investors, and companies that closely follow new platforms. Therefore, “ASGCT profiling” can make more people aware of the technology, even without a deal coming the same day. ASGCT itself emphasizes that the meeting is the place to learn about new technology and build relationships in the field. 3. Narrative effect in the market When a small biotech company like Circio gets stage time at such an important conference, the market can start to treat it as a more serious platform case. It is not the same as revenues or clinical data in humans, but it can raise interest and make it easier to get meetings, media coverage, and further attention.
    1 t sitten
    ·
    1 t sitten
    ·
    Thanks, Modernity !
  • 6 t sitten
    ·
    6 t sitten
    ·
    It will be exciting to follow Circio on May 11-15, 2026 at ASGCT's annual conference in Boston. The ASGCT conference is described as the largest and most prestigious global gene and cell therapy conference. Circio is among a select few chosen for an oral scientific presentation. This will clearly strengthen Circio's position and at the same time provide opportunities for in-depth collaboration and partner dialogues. The content of Circio's upcoming presentation will be announced during April 13. It will be exciting - I'm looking forward to it. Have a good weekend everyone!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q2 -tulosraportti
212 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 t sitten
    ·
    1 t sitten
    ·
    I'm very new to the game, but I've read up as much as I can on the stock. Nevertheless, I'm struggling to figure out what to do when it comes to when I should sell - yes, I can afford to lose the money, but it's still annoying. Does anyone have an opinion on what might happen this week, before Easter fully kicks off? I'm very keen to hold onto the stock as long as there is positive news
    16 min sitten
    ·
    16 min sitten
    ·
    If it were that simple to tell you what's going to happen next, there would be many stock market millionaires in the world.
  • 2 t sitten
    2 t sitten
    2 t sitten
    ·
    2 t sitten
    ·
    Strong 👍
  • 4 t sitten · Muokattu
    ·
    4 t sitten · Muokattu
    ·
    What do people think about CRNA now before Easter? I personally have rock-solid faith in CRNA, both in the short and long term. But do you think we'll see more buying pressure ig FOMO leading up to the Easter market close, or that people will secure profits and call it a day?
    2 t sitten
    ·
    2 t sitten
    ·
    I am also ready to buy more myself if it goes down.
    7 min sitten
    ·
    7 min sitten
    ·
    Yes
  • 6 t sitten
    ·
    6 t sitten
    ·
    I see that Collao finds it exciting to follow Circio at ASGCT's annual conference in Boston. Perhaps not everyone fully understands why. ASGCT profiling practically means that a company gains visibility and professional legitimacy at ASGCT, which is the largest and most central conference in gene and cell therapy. ASGCT describes the annual meeting as the largest and most comprehensive event in the field, with 7,000+ participants, 320+ exhibitors, and an audience that includes researchers, industry leaders, regulators, and clinicians. For Circio, it more specifically means three things: 1. Professional validation If an abstract is accepted, and especially if it is chosen for oral presentation, it is a mark of quality. Circio announced on March 18, 2026, that they had submitted two abstracts to ASGCT 2026, where one was chosen for oral presentation and one for a poster. The abstracts were to be published on April 13, 2026. 2. Increased visibility towards partners and investors ASGCT is not just an academic conference. It also gathers potential partners, BD people, investors, and companies that closely follow new platforms. Therefore, “ASGCT profiling” can make more people aware of the technology, even without a deal coming the same day. ASGCT itself emphasizes that the meeting is the place to learn about new technology and build relationships in the field. 3. Narrative effect in the market When a small biotech company like Circio gets stage time at such an important conference, the market can start to treat it as a more serious platform case. It is not the same as revenues or clinical data in humans, but it can raise interest and make it easier to get meetings, media coverage, and further attention.
    1 t sitten
    ·
    1 t sitten
    ·
    Thanks, Modernity !
  • 6 t sitten
    ·
    6 t sitten
    ·
    It will be exciting to follow Circio on May 11-15, 2026 at ASGCT's annual conference in Boston. The ASGCT conference is described as the largest and most prestigious global gene and cell therapy conference. Circio is among a select few chosen for an oral scientific presentation. This will clearly strengthen Circio's position and at the same time provide opportunities for in-depth collaboration and partner dialogues. The content of Circio's upcoming presentation will be announced during April 13. It will be exciting - I'm looking forward to it. Have a good weekend everyone!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1 200--
1 400--
1 500--
651--
7 445--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
15.4.
Menneet tapahtumat
2025 Q2 -tulosraportti
28.8.2025
2024 Q4 -tulosraportti
10.4.2025
2024 Q2 -tulosraportti
29.8.2024
2023 Q4 -tulosraportti
25.4.2024
2023 Q3 -tulosraportti
9.11.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q2 -tulosraportti
212 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
15.4.
Menneet tapahtumat
2025 Q2 -tulosraportti
28.8.2025
2024 Q4 -tulosraportti
10.4.2025
2024 Q2 -tulosraportti
29.8.2024
2023 Q4 -tulosraportti
25.4.2024
2023 Q3 -tulosraportti
9.11.2023

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 t sitten
    ·
    1 t sitten
    ·
    I'm very new to the game, but I've read up as much as I can on the stock. Nevertheless, I'm struggling to figure out what to do when it comes to when I should sell - yes, I can afford to lose the money, but it's still annoying. Does anyone have an opinion on what might happen this week, before Easter fully kicks off? I'm very keen to hold onto the stock as long as there is positive news
    16 min sitten
    ·
    16 min sitten
    ·
    If it were that simple to tell you what's going to happen next, there would be many stock market millionaires in the world.
  • 2 t sitten
    2 t sitten
    2 t sitten
    ·
    2 t sitten
    ·
    Strong 👍
  • 4 t sitten · Muokattu
    ·
    4 t sitten · Muokattu
    ·
    What do people think about CRNA now before Easter? I personally have rock-solid faith in CRNA, both in the short and long term. But do you think we'll see more buying pressure ig FOMO leading up to the Easter market close, or that people will secure profits and call it a day?
    2 t sitten
    ·
    2 t sitten
    ·
    I am also ready to buy more myself if it goes down.
    7 min sitten
    ·
    7 min sitten
    ·
    Yes
  • 6 t sitten
    ·
    6 t sitten
    ·
    I see that Collao finds it exciting to follow Circio at ASGCT's annual conference in Boston. Perhaps not everyone fully understands why. ASGCT profiling practically means that a company gains visibility and professional legitimacy at ASGCT, which is the largest and most central conference in gene and cell therapy. ASGCT describes the annual meeting as the largest and most comprehensive event in the field, with 7,000+ participants, 320+ exhibitors, and an audience that includes researchers, industry leaders, regulators, and clinicians. For Circio, it more specifically means three things: 1. Professional validation If an abstract is accepted, and especially if it is chosen for oral presentation, it is a mark of quality. Circio announced on March 18, 2026, that they had submitted two abstracts to ASGCT 2026, where one was chosen for oral presentation and one for a poster. The abstracts were to be published on April 13, 2026. 2. Increased visibility towards partners and investors ASGCT is not just an academic conference. It also gathers potential partners, BD people, investors, and companies that closely follow new platforms. Therefore, “ASGCT profiling” can make more people aware of the technology, even without a deal coming the same day. ASGCT itself emphasizes that the meeting is the place to learn about new technology and build relationships in the field. 3. Narrative effect in the market When a small biotech company like Circio gets stage time at such an important conference, the market can start to treat it as a more serious platform case. It is not the same as revenues or clinical data in humans, but it can raise interest and make it easier to get meetings, media coverage, and further attention.
    1 t sitten
    ·
    1 t sitten
    ·
    Thanks, Modernity !
  • 6 t sitten
    ·
    6 t sitten
    ·
    It will be exciting to follow Circio on May 11-15, 2026 at ASGCT's annual conference in Boston. The ASGCT conference is described as the largest and most prestigious global gene and cell therapy conference. Circio is among a select few chosen for an oral scientific presentation. This will clearly strengthen Circio's position and at the same time provide opportunities for in-depth collaboration and partner dialogues. The content of Circio's upcoming presentation will be announced during April 13. It will be exciting - I'm looking forward to it. Have a good weekend everyone!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1 200--
1 400--
1 500--
651--
7 445--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt
© 2026 Nordnet Bank AB.
Nordnet | Alvar Aallon katu 5 C, 3. krs | FI-00100 Helsinki